Therapeutical Potential of CB2 Receptors in Immune-Related Diseases

Author(s): Natascha Leleu-Chavain, Pierre Desreumaux, Philippe Chavatte, Regis Millet

Journal Name: Current Molecular Pharmacology

Volume 6 , Issue 3 , 2013

Become EABM
Become Reviewer
Call for Editor


The cannabinoid receptor CB2 is highly expressed in immune cells suggesting an important role in numerous diseases such as inflammation, cancer, osteoporosis and liver diseases relating to modulation of the immune system. As a consequence, activation of receptor CB2 is a promising therapeutic strategy for the treatment of a large range of diseases. Indeed, selective CB2 agonists display beneficial anti-inflammatory, anti-cancer and antifibrogenic properties and positive effects on liver disease and osteoporosis. This article reviews the CB2 involvement in the immune system and the promising therapeutical potential of selective CB2 agonists in the treatment of several immune-related diseases.

Keywords: Analgesic, anticancer, antifibrogenic, anti-inflammatory, cannabinoid receptors, CB2 agonists, immune system, immune-related diseases, liver disease, osteoporosis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 14 April, 2014
Page: [183 - 203]
Pages: 21
DOI: 10.2174/1874467207666140219122337
Price: $65

Article Metrics

PDF: 39